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ABSTRACT 
Objectives: The 1916 Royal Commission on Venereal Diseases was established in 
response to epidemics of syphilis and gonorrhoea in the UK. In the 100 years since the 
Venereal Diseases Act (1917), the UK has experienced substantial scientific, economic and 
demographic changes. We describe historical and recent trends in sexually transmitted 
infections (STIs) in the UK.  
Methods: We analysed surveillance data derived from STI clinics’ statistical returns from 
1917-2016. 
Results: Since 1918, gonorrhoea and syphilis diagnoses have fluctuated, reflecting social, 
economic and technological trends. Following spikes after World Wars I and II, rates 
declined before re-emerging during the 1960s. At that time, syphilis was more common in 
men, suggestive of transmission within the men who have sex with men (MSM) population. 
Behaviour change following the emergence of HIV/AIDS in the 1980s is thought to have 
facilitated a precipitous decline in diagnoses of both STIs in the mid-1980s. Since the early 
2000s, gonorrhoea and syphilis have re-emerged as major public health concerns, due to 
increased transmission among MSM and the spread of antimicrobial resistant gonorrhoea. 
Chlamydia and genital warts are now the most commonly diagnosed STIs in the UK and 
have been the focus of public health interventions, including the national human 
papillomavirus vaccination programme, which has led to substantial declines in genital warts 
in young people, and the National Chlamydia Screening Programme in England. Since the 
1980s, MSM, black ethnic minorities and young people have experienced the highest STI 
rates. 
Conclusion: Although diagnoses have fluctuated over the last century, STIs continue to be 
an important public health concern, often affecting more marginalised groups in society. 
Prevention must remain a public health priority and, as we enter a new era of sexual 
healthcare provision including online services, priority must be placed on maintaining prompt 
access for those at greatest risk of STIs.  
Word count: 300 (limit: 300) 
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KEY POINTS 
• Sexually transmitted infections (STIs) are a major public health concern and 
disproportionately affect men who have sex with men (MSM), black ethnic minorities 
and young people  
• Gonorrhoea and syphilis diagnoses have fluctuated considerably over the last 
century but have recently re-emerged especially among MSM, in part associated with 
HIV seroadaptive behaviours  
• STI interventions including the promotion of risk reduction, increased and improved 
testing, and vaccination have led to improvements in sexual health 
• As originally envisaged in 1917, there is a need to maintain free, confidential, open 
access sexual health services for those in need 
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INTRODUCTION 
The Royal Commission on Venereal Diseases of 1916 was established in response to 
widespread epidemics of syphilis and gonorrhoea in the UK. 1 At that time, syphilis was 
considered to be a leading cause of death, stillbirths, infant mortality and blindness, and 
gonorrhoea was a leading cause of infertility in women. 2 The subsequent passage of the 
Venereal Diseases Act of 1917 facilitated the provision of free, confidential, open-access 
sexually transmitted infection (STI) clinics in an attempt to prevent and control these 
infections. 1 3 While their epidemiology has changed remarkably over the last century, STIs 
continue to negatively impact the health and wellbeing of the population. 4  
For this reflective overview, we review and discuss STI surveillance data derived from 
mandatory statistical returns from STI clinics over the 100 years since the passage of the 
Venereal Diseases Act (1917). Data were primarily derived from aggregated statistical 
returns from STI clinics, but in more recent years were also derived from disaggregated 
electronic data from STI clinics and laboratories. 5 Data on gonorrhoea and syphilis were 
available from 1918 and 1922, respectively. Data on causes of morbidity were collected prior 
to this, however STI-related morbidity was understood to be severely underreported: 
“Syphilis had been, and remained, the despair of the statistician… Even in death a stigma 
was associated with it”. 2 
The aggregated returns from STI clinics contain limited demographic data, but provide key 
insights into historical STI trends. Gender data have been available for syphilis and 
gonorrhoea since 1925, and high male:female (M:F) ratios have been used to infer trends 
among gay, bisexual and other men who have sex with men (MSM). In the last 10 years, the 
availability of disaggregated data in some UK countries has enabled more in-depth 
exploration of the population sub-groups affected. The results of descriptive analyses are 
reported, with a focus on primary, secondary or early latent syphilis (hereafter: ‘syphilis’), 
gonorrhoea, chlamydia and first episode genital warts (hereafter: ‘genital warts’), and first 
episode genital herpes (hereafter: ‘genital herpes’).  
We used this review of surveillance data to compare and contrast the historical and current 
epidemiology of STIs, explore the factors contributing to the high diagnosis rates of STIs 
among select population subgroups in recent years, then discuss implications for the future 
provision of STI services.  
TRENDS IN GONORRHOEA AND SYPHILIS FROM 1918 TO THE EARLY 2000s 
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As previously described, 5 diagnoses of gonorrhoea and syphilis have fluctuated since 1918, 
reflecting social, economic and technological trends. Briefly, after the return of the armed 
forces to the UK at the end of World War I in 1918, diagnoses of syphilis and gonorrhoea 
both exceeded 35,000 annually (figures 1a and 1b and appendix tables 1 and 2). This was 
followed by a slow decline in cases for two decades, after which the number of diagnoses of 
both infections increased sharply in the mid-1940s at the end of World War II. Subsequently, 
there was a rapid decline in both infections, facilitated by the mass production of penicillin, 
until the number of diagnoses of both STIs reached a nadir the decade later. However, 
following the period of sexual liberation of the 1960s,6 diagnoses of both infections 
increased, with gonorrhoea returning to levels unseen since the late 1940s. In the case of 
syphilis, far more cases were reported in men (figure 1c), suggesting that sex between men 
became the predominant route of transmission. During the 1980s, there was another 
precipitous decrease in cases, thought to be due to behaviour change in response to the 
emergence of HIV/AIDS in the 1980s, the related public health campaigns, and the high 
case-fatality rate of HIV/AIDS at that time. While diagnoses of both STIs remained very low 
during the 1990s, there has been a re-emergence of both gonorrhoea and syphilis in MSM 
since 2000. 5 
In the following sections, we describe more recent trends in STIs in the UK then explore 
inequalities in STI distribution by population subgroups.  
 
RECENT STI TRENDS IN THE UK 
Currently, STI surveillance data from all UK countries are available for chlamydia, 
gonorrhoea and syphilis. In 2016, there was a combined total of 276,134 diagnoses of these 
STIs, with the most commonly reported (83.1%) being chlamydia; the majority of diagnoses 
of gonorrhoea (74.7%) and syphilis (94.4%) were in men, while more chlamydia diagnoses 
(57.2%) were in women. 7 Between 2012 and 2016, there were increases in the numbers of 
gonorrhoea (33.5%) and syphilis (93.3%), whereas chlamydia diagnoses decreased by 
5.0%. The majority (88.6%) of the overall total of these three STI diagnoses were made in 
English STI clinics, which heavily influences the UK-wide trends; slightly different trends 
were observed in the other countries of the UK. 8-10  
 
ADOLESCENTS AND YOUNG ADULTS 
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Teenagers and young adults experience the highest diagnosis rates of chlamydia and 
gonorrhoea (figure 2 and appendix figure 1); this has been recognised at least since the 
1980s, when roughly one third and one eighth of chlamydia and gonorrhoea diagnoses, 
respectively, were in those under 20 years. 11 In the 1990s, 16 to 19 year-old women had the 
highest diagnosis rates of gonorrhoea, chlamydia and genital warts, and the second highest 
rate (after 20 to 24 year old women) of genital herpes. 12 Currently, among 15 to 24 year 
olds, men are three and women are 11 times more likely to be diagnosed with chlamydia, 
gonorrhoea, or syphilis than their counterparts aged 25 to 64 years (figure 2). The age 
disparity in STI rates is likely due to higher partner turnover in young people. Compared to 
older people, those aged 16 to 24 are most likely to report a new sex partner or two or more 
sex partners of the opposite sex in the previous year. 13  
There is a marked disproportionality in diagnosis rates by gender in those aged 15 to 19 
years and women are now 2.8 times more likely to be diagnosed with chlamydia, gonorrhoea 
or syphilis than men in this age group (figure 2).11  To some extent the disparity will reflect 
improved access to STI testing among younger women in a range of clinical settings, 
including through the National Chlamydia Screening Programme (NCSP) in England,4 but it 
may also be due to disassortative sexual mixing patterns between young women and older 
male partners14 15 or greater biological susceptibility to STIs among younger women. 16 
Chlamydia is the most commonly diagnosed STI in the UK, and the highest diagnosis rates 
are reported in those under the age of 25 years. 4 Testing was only readily available since 
the mid-1990s, and since then widespread testing, which in England was facilitated by the 
NCSP, led to a rapid increase in chlamydia diagnoses. 17 The NCSP offers opportunistic 
screening of sexually active young people aged 15 to 24 years with the aim of increasing the 
detection of chlamydia and reducing the prevalence of associated sequelae.  Chlamydia 
screening programmes have not been implemented in other countries of the UK. 18 However, 
widespread chlamydia testing in Scotland was driven by changes implemented following the 
publication of the Scottish Intercollegiate Guideline Network guidance in 2000; this 
recommended urine sampling and the use of sensitive, specific nucleic acid amplification 
tests. 19  
Historically, young women have also experienced much higher rates of genital warts than 
older women, 12 but recent years have seen marked declines in the younger age groups 
(appendix figure 2), likely associated with the introduction of the UK schools-based human 
papillomavirus vaccine (HPV) programme in 2008. 20 In England in 2016, the diagnosis rate 
of genital warts in 15 to 17 year old girls, most of whom would have been offered the 
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quadrivalent vaccine when aged 12 to 13 years, was 121.5 per 100,000 population, a 72% 
decrease relative to 2009. There has been a 62% decrease in the diagnosis rate of genital 
warts in 15 to 17 year old boys over the same time period, providing evidence of herd 
protection from the high coverage female HPV vaccination programme. 4 Similar reductions 
have not been seen in older age-groups. This school-aged vaccination programme offers no 
protection to MSM so a targeted HPV vaccination programme for MSM will be introduced in 
England in April 2018 following an initial pilot that ran from 2016.. 21 HPV vaccination has 
been offered opportunistically to MSM in Northern Ireland since October 2016 and Scotland 
since July 2017. HPV vaccination of MSM will provide direct protection against HPV infection 
with the aim of reducing the incidence of genital warts and HPV-related cancers. 
 
GAY, BISEXUAL AND OTHER MEN WHO HAVE SEX WITH MEN 
In the last decade, MSM have continued to be disproportionately affected by STIs including 
HIV, as well as blood-borne infections, such as hepatitis B and C, and sexually transmissible 
enteric infections, such as Shigella flexneri. 5 22-28 While only 11% of all attendances at 
English STI clinics in 2016 were by MSM, 53% of all gonorrhoea and syphilis diagnoses 
were made in this group. The number of diagnoses of these bacterial STIs in MSM in 
England has risen three- to five-fold over the last decade (figure 3). In 2016, the total number 
of syphilis diagnoses at STI clinics in England increased to 5,920, the largest number 
reported since 1949; the majority (81%) were in MSM. Similarly, in Scotland, syphilis 
diagnoses have doubled since 2014 to 356 in 2016, the largest number recorded since 
1951; the majority (83%) were made in MSM. 29 
Several factors likely explain these increases.  Studies suggest that increased frequency of 
condomless anal intercourse (CAI), sometimes associated with HIV sero-adaptive 
behaviours, group sex facilitated by geosocial networking applications and ‘chemsex’, may 
play a role. 30 31 The seven-fold rise in gonorrhoea diagnoses among MSM in England 
between 2007 and 2015, which has been mirrored in Wales and Northern Ireland, 9 10 and to 
a similar extent in Scotland based on male rectal diagnoses8 may also be partly explained by 
increased detection following the change in the national gonorrhoea testing guideline to 
include asymptomatic screening at extra-genital sites in MSM using highly sensitive nucleic 
acid amplification tests. 32-36 In England, after years of successive increases since 2008, the 
number of gonorrhoea diagnoses in MSM decreased 22% to 17,584 between 2015 and 
2016.  This decline coincided with reductions in HIV diagnoses which have been associated 
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with improved HIV testing uptake at STI clinics, including repeat testing; prompt initiation of 
anti-retroviral treatment following diagnosis and irrespective of immune status to prevent 
onward transmission (‘treatment as prevention’); and private access of HIV pre-exposure 
prophylaxis. 37 38 Increased STI testing uptake at STI clinics occurred in parallel, and may 
have helped facilitate prompt identification and treatment of asymptomatic infection, reducing 
the likelihood of secondary transmission. More targeted, quarterly syphilis testing, especially 
in HIV-positive MSM, may be required to effect a reduction in syphilis incidence 39 40.  
 
BLACK MINORITY ETHNIC POPULATIONS 
In 2016, data from England showed that diagnosis rates of chlamydia and gonorrhoea in 
black Caribbean populations were 4 times those of the general population. Similarly, in 
Wales in 2015, the gonorrhoea diagnosis rate in black populations was 3 times that of white 
populations.9 The ethnic disparity in poor sexual health is even starker in the case of 
trichomoniasis where, in 2016 in England, the diagnosis rate in black Caribbean women was 
14 times that of all women. There is considerable heterogeneity in STI diagnoses among 
black ethnic minority (BME) groups: black Caribbean and black non-Caribbean/non-African 
people (hereafter: ‘any other black background’) have the highest diagnosis rates of many 
STIs of all ethnic groups, while black Africans have relatively lower rates (figure 4). 41 42   
Disproportionately higher rates of gonorrhoea in black Caribbean people in urban areas 
have been recognised since the 1950s and have persisted to the present day. 42-47 Since the 
mass wave of migration of people from the Caribbean and elsewhere in the British 
Commonwealth to the UK after the British Nationality Act of 1948, 48 most black Caribbean 
and other BME people have resided in the most deprived urban areas of England. 42 There 
is an inextricable link between the socioeconomic context of neighbourhoods and the health 
outcomes of their residents. 49 Sexual health is no exception, and evidence suggests that 
socioeconomic deprivation plays a role in ethnic disparities in STI diagnosis rates, although it 
does not fully explain it. 42 Behavioural factors, which are themselves influenced by 
socioeconomic environment, likely contribute. The findings of a national probability sample 
indicate that men of black Caribbean or any other black backgrounds are most likely to 
report higher numbers of recent sexual partners and concurrent partnerships which, coupled 
with assortative sexual mixing patterns, may be maintaining endemic levels of gonorrhoea 
transmission in these communities.50 Data from England also suggest that BME MSM are 
more likely to be diagnosed with a bacterial STI and are at greater risk of HIV than white 
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British MSM, a disparity which may be explained by differences in health-seeking behaviour 
or sexual mixing patterns. 51 52  
 
DISCUSSION 
Since the introduction of the Venereal Diseases Act (1917) 100 years ago, the complex 
interplay of historical events, changes in cultural mores, and technological and service 
developments are clearly reflected in the STI surveillance data presented. 5 More recently, 
there has been a re-emergence of gonorrhoea and syphilis among MSM, likely associated, 
at least in part, with increasing CAI as a result of HIV treatment optimism. 30 53 54 The rise in 
gonorrhoea diagnoses is of particular concern given the propensity of Neisseria gonorrhoeae 
to develop resistance to successive antimicrobials used for treatment. 55 56 However, there 
have also been notable successes in STI prevention in the last decade: following the 
implementation of the national HPV vaccination programme in school-aged girls, diagnoses 
of genital warts have declined markedly in young adults, and future reductions in HPV-
related cancers are anticipated. w1 2  
Accurate and easy to perform diagnostic tests are fundamental for early diagnosis and 
effective treatment, as well as informing our understanding of the epidemiology of STIs. The 
key development in the last 100 years was a shift in the method of confirming a bacterial STI 
diagnosis from one based on symptoms to one of defining asymptomatic people as carriers 
of a pathogen. For example, in 1917 syphilis diagnosis depended solely upon microscopic 
identification of the organism but, with advances in immunological techniques, serological 
assays were used routinely to provide more accurate results by the 1930s. In the 1970s the 
creation of monoclonal antibodies allowed the production of highly specific methods of 
testing patients for infections. w3 The development of nucleic acid testing in the 1990s led to 
accurate, high volume, low cost tests which are now routinely used in the UK, w4 5 and are 
likely to have contributed to the sharp rise in gonorrhoea diagnoses in England after 2010. w6 
Regular testing for STIs, especially in those individuals at higher risk of infection, has been 
promoted through both targeted, public facing campaign work and changes in clinical and 
diagnostic practice. For example, clinical recommendations that MSM should test regularly 
for HIV (and thus, by extension, STIs) have been reinforced by promoting testing among 
MSM through campaigns such as National HIV Testing Week in England and the European 
HIV-Hepatitis Testing Week. National provision of pre-exposure prophylaxis for HIV (PrEP) 
has been forecasted to reduce STIs in MSM due to the increased STI screening required for 
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PrEP management. w7 This has not yet been observed in practice, but the NHS-funded HIV 
PrEP programme in Scotland and national implementation trials in Wales and England will 
provide a unique opportunity to assess this on a national scale. w8-10 
Promoting condoms, early diagnosis, access to effective treatments and effectual partner 
notification are key components of the prevention and control of STIs by interrupting onward 
transmission of infection, especially in high risk groups. 38 Access to STI clinics has 
improved over the last 10 years and, there are now over 4 million attendances at STI clinics 
annually w11 and this marked improvement is in part due to the introduction of access targets 
for STI clinics in England in 2006. w12 Although in 2011 nearly everyone (99.9%) was offered 
an appointment within 48 hours, w13 there has since been a worrying worsening of service 
access, especially for symptomatic patients and women. w14 Ensuring prompt access to 
those in need should remain a priority, especially given significant reorganisations in sexual 
health service provision and reductions in spend on services. w15-17   
In the current climate of reduced funding, cost saving measures, such as the scale up of 
online service provision using STI self-sampling kits, are being pursued. w17 w18 An objective 
of a new service model for London residents is to direct patients to online services rather 
than attending terrestrial STI clinics. w18 This has the potential to increase access to 
testing,w19 but care must be taken to avoid exacerbating sexual health inequality through the 
digital divide; w20-22 this is of particular concern for BME people from socioeconomically 
deprived areas, who experience disproportionate sexual ill-health.42 It is vital that STI 
surveillance systems continue to adapt to capture this shift in service provision and thereby 
enable evaluation of its real-life impact. w23 
There are promising developments on the horizon. Recently published case-control data 
from New Zealand provide evidence of a protective effect of group B meningococcal vaccine 
for gonorrhoea; w24 25 if this is corroborated by robust clinical trial data, improved control of 
gonorrhoea is potentially within reach. Furthermore, the widespread use of geosocial 
networking applications presents novel opportunities for both sexual health education and 
promotion. w26 New developments in STI prevention should supplement more traditional 
approaches:  condom use  is a highly effective intervention to control the transmission of 
STIs, and should continue to be promoted.w27  
Despite the myriad economic and societal changes over the last century, STIs continue to be 
associated with stigma, discrimination and socio-economic inequality. The means to prevent 
and control STIs are readily available, and in the UK the key mechanism for their delivery is 
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through open access clinics. As we enter a new era of sexual healthcare provision, we must 
ensure that innovation in interventions and their delivery continue to meet population needs 
as well as reduce health inequalities.    
  
Page 12 of 20 
100 years of STI Surveillance in the UK 
Version 1.3.2 (2nd March 2018) 
 
Acknowledgements: The authors acknowledge the contribution of all sexual health 
services to the surveillance of STIs since the inception of these surveillance systems. They 
also thank Ian Simms for his insight on the history of the UK’s STI surveillance systems and 
Peter Kirwan for further editorial input.  
Author contributions: HM, PB and GH designed the data analysis plan. HM, PB, DO, SD 
and MC performed the data analysis. HM wrote the first draft of the paper, which was 
reviewed and edited by all coauthors.  
Competing interests: The authors declare no competing interests. 
Funding: No additional funding was received for this analysis. 
Ethics statement: As GUMCAD is a routine public health surveillance activity, no specific 
consent was required from the patients whose data were used in this analysis. In its role 
providing infectious disease surveillance Public Health England has permission to handle 
data obtained by GUMCAD under Regulation 3 of the Health Service (Control of Patient 
Information) Regulations 2002. Public Health Wales, the Public Health Agency and Health 
Protection Scotland have a statutory function to carry out surveillance of communicable 
disease.  
The Corresponding Author has the right to grant on behalf of all authors and does grant on 
behalf of all authors, a non-exclusive licence (as UK Crown employees) on a worldwide 
basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in 
STI and any other BMJPGL products and sub-licences such use and exploit all subsidiary 
rights, as set out in our licence http://group.bmj.com/products/journals/instructions-for-





Page 13 of 20 
100 years of STI Surveillance in the UK 




1. The Report of the Royal Commission on Venereal Diseases. British Medical Journal 
1916;1(2879):345-46. doi: 10.1136/bmj.1.2879.345-b 
2. Osler W. The campaign against venereal diseases. Br Med J 1917;1(2943):694-96. doi: 
10.1136/bmj.1.2943.694 
3. Simms I, Hughes G. 1917: responding to the challenge posed by venereal disease. Sex 
Transm Infect. In press. 2017 
4. Public Health England. Sexually transmitted infections and chlamydia screening in 
England, 2016. Health Protection Report. 11(20), Advanced Access report published 
6 June 2017. Available at: https://www.gov.uk/government/statistics/sexually-
transmitted-infections-stis-annual-data-tables. Accessed 7th June 2017.  
5. Hughes G, Field N. The epidemiology of sexually transmitted infections in the UK: impact 
of behavior, services and interventions. Future Microbiology 2015;10(1):35-51. doi: 
10.2217/fmb.14.110 
6. Silies E-M. Taking the Pill after the ‘sexual revolution’: female contraceptive decisions in 
England and West Germany in the 1970s. European Review of History: Revue 
européenne d'histoire 2015;22(1):41-59. doi: 10.1080/13507486.2014.983431 
7. Public Health England. Table 9: Selected STI diagnoses and rates in the UK by gender 
and age group, 2012 to 2016. Sexually transmitted infections (STIs): annual data 
tables. Available at: https://www.gov.uk/government/statistics/sexually-transmitted-
infections-stis-annual-data-tables. Accessed 3rd November 2017 
8. Health Protection Scotland Weekly Report. Genital chlamydia and gonorrhoea infection in 
Scotland: laboratory diagnoses 2007 - 2016. Available at: 
http://www.hps.scot.nhs.uk/ewr/article.aspx. Accessed 3 November, 2017.  
9. Public Health Wales. HIV and STI trends in Wales. Data tables, June 2017. Available at: 
http://www.wales.nhs.uk/sitesplus/888/news/45989. Accessed 3rd November, 2017.  
10. Public Health Agency. Sexually Transmitted Infection surveillance in Northern Ireland 
2016 - An analysis of data for the calendar year 2015. Available at: 
http://www.publichealth.hscni.net/directorate-public-health/health-protection/sexually-
transmitted-infections. Accessed 3rd November, 2017.  
11. Cowan FM, Mindel A. Sexually transmitted diseases in children: adolescents. 
Genitourinary Medicine 1993;69(2):141-47. 
12. Nicoll A, Catchpole M, Cliffe S, et al. Sexual health of teenagers in England and Wales: 
analysis of national data. BMJ 1999;318(7194):1321-22. doi: 
10.1136/bmj.318.7194.1321 
Page 14 of 20 
100 years of STI Surveillance in the UK 
Version 1.3.2 (2nd March 2018) 
 
13. Mercer CH, Tanton C, Prah P, et al. Changes in sexual attitudes and lifestyles in Britain 
through the life course and over time: findings from the National Surveys of Sexual 
Attitudes and Lifestyles (Natsal). The Lancet 2013;382(9907):1781-94. 
14. Ford K, Sohn W, Lepkowski J. Characteristics of Adolescents' Sexual Partners and Their 
Association with Use of Condoms and Other Contraceptive Methods. Family 
Planning Perspectives 2001;33(3):100-32. doi: 10.2307/2673765 
15. Kraut-Becher JR, Aral SO. Patterns of age mixing and sexually transmitted infections. 
International Journal of STD & AIDS 2006;17(6):378-83. doi: 
doi:10.1258/095646206777323481 
16. McCree DH, Rompalo AM. Biological and Behavioral Risk Factors Associated with 
STDs/HIV in Women: Implications for Behavioral Interventions. In: Aral SO, Douglas 
JM, eds. Behavioral Interventions for Prevention and Control of Sexually Transmitted 
Diseases. Boston, MA: Springer US 2007:310-24. 
17. Chandra N, Soldan K, Dangerfield C, et al. Filling in the gaps: estimating numbers of 
chlamydia tests and diagnoses by age group and sex before and during the 
implementation of the English National Screening Programme, 2000 to 2012. Euro 
Surveill. 2017;22(5):pii=30453. DOI: http://dx.doi.org/10.2807/1560-
7917.ES.2017.22.5.30453. Accessed 18th August, 2017.  
18. Hughes G, Lowndes CM. Epidemiology of sexually transmitted infections: UK. Medicine 
2014;42(6):281-86. doi: http://dx.doi.org/10.1016/j.mpmed.2014.03.002 
19. Scottish Intercollegiate Guidelines Network. Management of genital Chlamydia 
trachomatis infection. SIGN 109. March 2009. Available at: 
http://www.sign.ac.uk/sign-109-management-of-genital-chlamydia-trachomatis-
infection.html. Accessed 17th November, 2017.  
20. Howell-Jones R, Soldan K, Wetten S, et al. Declining Genital Warts in Young Women in 
England Associated With HPV 16/18 Vaccination: An Ecological Study. Journal of 
Infectious Diseases 2013;208(9):1397-403. doi: 10.1093/infdis/jit361 
21. Department of Health and Social Care. HPV vaccination programme for men who have 
sex with men. Available at: https://www.gov.uk/government/news/hpv-vaccination-
programme-for-men-who-have-sex-with-men. Accessed 16th February, 2018.  
22. Gilbart VL, Simms I, Jenkins C, et al. Sex, drugs and smart phone applications: findings 
from semistructured interviews with men who have sex with men diagnosed with 
Shigella flexneri 3a in England and Wales. Sexually Transmitted Infections 2015 doi: 
10.1136/sextrans-2015-052014 
23. Public Health England. Shigella infections not known to be associated with travel in 
England: laboratory reports 2004 to 2016. Health Protection Report 2016;10 (22) 
Page 15 of 20 
100 years of STI Surveillance in the UK 
Version 1.3.2 (2nd March 2018) 
 
24. Simms I, Field N, Jenkins C, et al. Intensified Shigellosis epidemic associated with 
sexual transmission in men who have sex with men - Shigella flexneri and S. sonnei 
in England, 2004 to end of February 2015. Euro Surveill. 2015;20(15):pii=21097. 
Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21097. 
Accessed 4th June 2015. 2015 
25. Beebeejaun K, Degala S, Balogun K, et al. Outbreak of hepatitis A associated with men 
who have sex with men (MSM), England, July 2016 to January 2017. Euro Surveill. 
2017;22(5):pii=30454. DOI: http://dx.doi.org/10.2807/1560-
7917.ES.2017.22.5.30454. Accessed 5th May, 2017.  
26. Public Health England. Hepatitis A outbreak (England) investigation (2016-2017). 
Available at: https://www.gov.uk/government/publications/hepatitis-a-outbreak-
england-investigation-2016-2017. Accessed 4th July 2017.  
27. Simms I, Gilbart VL, Byrne L, et al. Identification of verocytotoxin-producing Escherichia 
coli O117:H7 in men who have sex with men, England, November 2013 to August 
2014. Euro Surveill. 2014;19(43):pii=20946. Available online: 
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20946. Accessed 20 
August 2015.  
28. Shankar AG, Mandal S, Ijaz S. An outbreak of hepatitis B in men who have sex with men 
but identify as heterosexual. Sexually Transmitted Infections 2016 doi: 
10.1136/sextrans-2015-052490 
29. Health Protection Scotland. Syphilis in Scotland 2016: update. HPS Weekly Report 
2017; 51 (33): 278-287. Available at: 
http://www.hps.scot.nhs.uk/bbvsti/wrdetail.aspx?id=75392&wrtype=6. Accessed 17 
November, 2017.  
30. Aghaizu A, Wayal S, Nardone A, et al. Sexual behaviours, HIV testing, and the 
proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000–13: a 
serial cross-sectional study. The Lancet HIV 2016;3(9):e431-e40. doi: 
http://dx.doi.org/10.1016/S2352-3018(16)30037-6 
31. Daskalopoulou M, Rodger AJ, Phillips AN, et al. Condomless sex in HIV-diagnosed men 
who have sex with men in the UK: prevalence, correlates, and implications for HIV 
transmission. Sexually Transmitted Infections 2017 doi: 10.1136/sextrans-2016-
053029 
32. Ison C. GC NAATs: is the time right? Sexually Transmitted Infections 2006;82(6):515. 
doi: 10.1136/sti.2006.022731 
Page 16 of 20 
100 years of STI Surveillance in the UK 
Version 1.3.2 (2nd March 2018) 
 
33. Health Protection Agency. Guidance for gonorrhoea testing in England and Wales, 
February 2010. Available at http://www.bashh.org/documents/2580.pdf. Accessed 
4th June 2015  
34. Fifer H, Ison CA. Nucleic acid amplification tests for the diagnosis of Neisseria 
gonorrhoeae in low-prevalence settings: a review of the evidence. Sexually 
Transmitted Infections 2014;90(8):577-79. doi: 10.1136/sextrans-2014-051588 
35. Savage EJ, Marsh K, Duffell S, et al. Rapid increase in gonorrhoea and syphilis 
diagnoses in England in 2011. Eurosurveillance 2012;17(29):20224. doi: 
doi:https://doi.org/10.2807/ese.17.29.20224-en 
36. Public Health England. Sexually transmitted infections and chlamydia screening in 
England, 2015. Health Protection Report. 10(22), Advanced Access report published 
5 July 2016. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/55914
5/hpr2216_crrctd3.pdf. Accessed 16th February 2018.  
37. Nwokolo N, Whitlock G, McOwan A. Not just PrEP: other reasons for London's HIV 
decline. The Lancet HIV;4(4):e153. doi: 10.1016/S2352-3018(17)30044-9 
38. Brown A, Mohammed H, Ogaz D, et al. Fall in new HIV diagnoses among men who have 
sex with men (MSM) at selected London sexual health clinics since early 2015: 
testing or treatment or pre-exposure prophylaxis (PrEP)? . Euro Surveill. 
2017;22(25):pii=30553. DOI: http://dx.doi.org/10.2807/1560-
7917.ES.2017.22.25.30553. Accessed 30 June 2017.  
39. Gray RT, Hoare A, Prestage GP, et al. Frequent Testing of Highly Sexually Active Gay 
Men is Required to Control Syphilis. Sexually Transmitted Diseases 2010;37(5):298-
305. doi: 10.1097/OLQ.0b013e3181ca3c0a 
40. Tuite AR, Fisman DN, Mishra S. Screen more or screen more often? Using mathematical 
models to inform syphilis control strategies. BMC Public Health 2013;13(1):606. doi: 
10.1186/1471-2458-13-606 
41. Le Polain De Waroux O, Harris RJ, Hughes G, et al. The epidemiology of gonorrhoea in 
London: a Bayesian spatial modelling approach. Epidemiology & Infection 
2014;142(01):211-20. doi: doi:10.1017/S0950268813000745 
42. Furegato M, Chen Y, Mohammed H, et al. Examining the role of socioeconomic 
deprivation in ethnic differences in sexually transmitted infection diagnosis rates in 
England: evidence from surveillance data. Epidemiology and Infection 2016:1-10. 
doi: 10.1017/S0950268816001679 
43. Beveridge MM. Source of Infection with Gonorrhoea in Various Ethnic Groups. British 
Journal of Venereal Diseases 1962;38(3):154-56. 
Page 17 of 20 
100 years of STI Surveillance in the UK 
Version 1.3.2 (2nd March 2018) 
 
44. Laird SM. Gonorrhoea in the Manchester Region. British Journal of Venereal Diseases 
1962;38(4):181-88. 
45. Watt L. Gonorrhoea in ManchesterIncidence of Repeated Infections. British Journal of 
Venereal Diseases 1958;34(1):9-13. 
46. Low N, Daker-White G, Barlow D, et al. Gonorrhoea in inner London: results of a cross 
sectional study. BMJ 1997;314(7096):1719. doi: 10.1136/bmj.314.7096.1719 
47. Low N, Sterne JAC, Barlow D. Inequalities in rates of gonorrhoea and chlamydia 
between black ethnic groups in south east London: cross sectional study. Sexually 
Transmitted Infections 2001;77(1):15-20. doi: 10.1136/sti.77.1.15 
48. British Nationality Act 1948. Available at: http://www.legislation.gov.uk/ukpga/Geo6/11-
12/56/introduction. Accessed 18th August, 2017.  
49. Pickett KE, Pearl M. Multilevel analyses of neighbourhood socioeconomic context and 
health outcomes: a critical review. Journal of Epidemiology and Community Health 
2001;55(2):111-22. doi: 10.1136/jech.55.2.111 
50. Wayal S, Hughes G, Sonnenberg P, et al. Examining ethnic variations in sexual 
behaviours and sexual health markers: evidence from a British national probability 
sample survey. The Lancet Public Health In press 2017 
51. Mohammed H, Furegato M, Hughes G. P068 Inequalities in sexually transmitted 
infection risk among black and minority ethnic men who have sex with men in 
England. Sexually Transmitted Infections 2016;92(Suppl 1):A42-A42. doi: 
10.1136/sextrans-2016-052718.122 
52. Desai S, Nardone A, Hughes G, et al. HIV incidence in an open national cohort of men 
who have sex with men attending sexually transmitted infection clinics in England. 
HIV Medicine 2017;18(9):615-22. doi: 10.1111/hiv.12498 
53. Van de Ven P, Rawstorne P, Nakamura T, et al. HIV treatments optimism is associated 
with unprotected anal intercourse with regular and with casual partners among 
Australian gay and homosexually active men. International Journal of STD & AIDS 
2002;13(3):181-83. doi: doi:10.1258/0956462021924884 
54. Fenton KA, Imrie J. Increasing Rates of Sexually Transmitted Diseases in Homosexual 
Men in Western Europe and the United States: Why? Infectious Disease Clinics 
2005;19(2):311-31. doi: 10.1016/j.idc.2005.04.004 
55. Public Health England. High level azithromycin resistant gonorrhoea in England. 
Available at: https://www.gov.uk/government/publications/high-level-azithromycin-
resistant-gonorrhoea-in-england. Accessed 6th Dec, 2016.  
56. Public Health England. Surveillance of antimicrobial resistance in Neisseria gonorrhoeae 
in England and Wales. Key findings from the Gonococcal Resistance to 
Page 18 of 20 
100 years of STI Surveillance in the UK 
Version 1.3.2 (2nd March 2018) 
 
Antimicrobials Surveillance Programme (GRASP) - Data to June 2017. Available at: 
https://www.gov.uk/government/publications/gonococcal-resistance-to-antimicrobials-
surveillance-programme-grasp-report/. Accessed 3rd November 2017  
Page 19 of 20 
100 years of STI Surveillance in the UK 
Version 1.3.2 (2nd March 2018) 
 
Figure 1 - a. Number of diagnoses of gonorrhoea, 1918-2016,  b. number of diagnoses 
of primary, secondary and early latent syphilis, 1922-2016 and c. ratio of diagnoses of 
gonorrhoea and primary, secondary and early latent syphilis in men and women, 
1925-2016; sexually transmitted infection clinics, United Kingdom *⁰† 
Figure 1a 
Figure 1b  
Figure 1c  
Different scales are used for the y-axes of each of the above graphs 
* Data from Northern Ireland are available starting the year 1991 
⁰Scotland data from 1995 are unavailable  
† Data from STI clinics’ routine surveillance returns and routine laboratory reporting 
Syphilis data is only Scotland 1922-1930; England, Wales and Scotland 1931-1990; and all 
countries from 1991 onwards (except for 1995, which is missing Scotland data) 
Gonorrhoea data is only England and Wales 1918- 1921; England, Wales and Scotland 
1922-1990; and all countries 1991 onwards (except for 1995, which is missing Scotland 
data) 
 
Figure 2. Rates of chlamydia, gonorrhoea or syphilis* diagnoses † by age-group and 
gender, 2016, United Kingdom  
* Primary, secondary and early latent stages 
† Data from STI clinics’ routine surveillance returns and routine laboratory reporting  
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Figure 3. Number of new diagnoses of selected sexually transmitted infections (STIs) 
in men who have sex with men attending STI clinics†, 2007–2016, England  
Different scales are used for the y-axes for i. chlamydia and gonorrhoea and ii. genital 
herpes, genital warts, and syphilis  
* First episode; ** Primary, secondary and early latent 
† Data from routine specialist and non-specialist sexual health services’ returns to the 
GUMCAD surveillance system 
 
Figure 4. Rates of selected sexually transmitted infection (STI) diagnoses* by ethnic 
group and STI, 2016, England 
* Data from routine specialist and non-specialist sexual health services’ returns to the 
GUMCAD surveillance system   
** First episode.  ‡ Primary, secondary and early latent 
Appendix Figure 1. Rates of selected sexually transmitted infection (STI) diagnoses† 
by gender and age group‡, 2012–2016, United Kingdom 
† Data from STI clinics’ routine surveillance returns and routine laboratory reporting; ‡ Years 
* First episode; ** Primary, secondary and early latent 
Different scales are used for the y-axes of different STIs 
Appendix Figure 2. Rates of first episode genital warts diagnoses† by gender and age 
group‡, 2012–2016,  England 
† Data from routine specialist and non-specialist sexual health services’ returns to the 
GUMCAD surveillance system; ‡ Years 
* First episode 
 
